A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S T | U | V | W | X | Y | Z

Articles are indexed by drug names, trade names and disease terms. Bold entries refer to major references.

Key Word / Drug Name
Issue #: Page #

A

abametapir5:12
ABP 7982:12
Abrilada™1:8; 2:10,11
acne5:12
actinic keratosis5:8-9
Aczone®2:10
adalimumab1:8; 2:10,11; 4:12
afamelanotide2:10
AGLE-1025:12
Aklief®1:8; 2:1-2
alopecia areata3:10; 4:6-11
Amzeeq™1:8; 2:10
androgen receptor inhibitor5:12
anesthetic (topical)1:8
anti-aging2:3-9,10
anti-cancer2:10; 4:9,12; 5:5, 8-12
antineoplastic5:12
antioxidants2:3-9
anti-wrinkle2:3-9,10
apical sodium-dependent bile acid transporter1:8
apremilast2:10
Arazlo™2:10,12
ART-124:12
atezolizumab5:12
atopic dermatitis1:8; 2-10; 3:10; 4:6-12
autoimmune disease3:5-9; 4:8-9; 5:8-11
Avsola™1:8; 2:11; 3:10

B

baricitinib3:10; 4:6-11
basal cell carcinoma5:8-11,12
Behçet’s disease2:10
belimumab2:11
Benlysta®2:11
betamethasone dipropionate2:11; 5:12
biologic1:8; 2:10,11; 3:1-4,10; 4:12; 5:12
biosimilar1:8;2:10-12; 4:12
blistering disorder5:12
BMS-9861654:7
botulinumtoxin type A2:10
BRAF kinase inhibitor5:12
bullous pemphigoid4:8-12; 5:8-11

C

calcipotriene2:11; 5:12
carbon dioxide laser4:2-3
CD-directed cytolytic antibody2:10
celiac disease5:1-7
cellulite4:12
cetirizine hydrochloride1:8; 2:11
chemoprevention5:8-11
clascoterone5:12
collagenase clostridium histolyticum4:12
comorbidities5:1-7
cortexolone 17α-propionate5:12
corticosteroid2:11; 5:12
Cotellic®5:12
crisaborole3:10
cryoglobulinemic vasculitis3:5-9
cryotherapy4:2
cyclophosphamide3:7
cytotoxic agent3:7

D

dapsone2:10
dermal filler2:10
dermatosis papulose nigra4:1-5
diabetes5:1-7
diet & skin aging2:3-9
diode laser4:2
doxycycline5:11
Duobrii™2:11; 5:12
dupilumab2:10; 4:12
Dupixent®2:10; 4:12
dyslipidemia5:3-4
dystrophic epidermolysis bullosa5:12

E

eczema1:8; 2:10; 3:10; 4:6-12
electrodessication4:2
Enbrel®2:11
Enstilar®2:11
eosinophilic granulomatosis with polyangiitis3:5-9
epithelial tumors1:1-4
epithelioid sarcoma2:10,12
ER-0044:12
erbium-doped fractionated laser4:1-5
erythropoietic protoporphyria2:10
Eskata™1:1-4
etanercept2:11
Eticovo™2:11
Eucrisa®3:10
excision4:1-2
extracellular matrix (ECM)2:4; 5:12
extracellular vesicle therapy5:12

F

filaggrin gene1:5
filgotinib4:7
foods impacting MMPs2:3-9

G

gastrointestinal disease5:5
gene therapy5:12
genetic counseling1:6
glucocorticoids3:7
glycation2:3-9
golimumab5:12
graft-versus-host disease2:10
granulomatosis with polyangiitis2:10; 3:5-9
guselkukmab4:12
gut microbiome2:5,7

H

Hadlima™2:11
hair loss3:10
halobetasol propionate2:11
hedgehog pathway inhibitor5:12
hidradenitis suppurativa4:7,9
histamine-1 receptor antagonist1:8; 2:11
HP401:1-4
Hulio®4:12
Humira®2:10,11
hyaluronic acid2:10
hydrogen peroxide topical solution1:1-4
hyperglycemia2:5
hypertension5:3-4

I

ichthyosis1:5-7
immunoglobulin A vasculitis3:5-9
immunotherapy2:10; 5:12
infection4:9
INCB547074:7
inflammation2:3-9,10; 3:5-9
inflammatory bowel disease5:1-7
infliximab1:8; 2:11; 3:10
interleukin-125:12
interleukin-132:10
interleukin-232:11; 3:1-4; 4:12; 5:12
interleukin-42:10; 4:12
itacitinib4:7

J

Jakafi®2:10
jakinibs4:6-11
Janus kinase (JAK) inhibitor2:10; 3:10; 4:6-11
Jeuveau™2:10
Juvéderm Voluma® XC2:10
Jynneos™2:11

K

keratinization disorder1:5-7
Keytruda®2:10; 4:12
Koselugo®3:10; 4:12
KTP laser4:1-5

L

laser4:1-5
lebrikizumab1:8
lice5:12
lichen planus pilaris4:9
lidocaine1:8

M

malignancy2:10; 4:9,12; 5:5
maralixibat1:8
matrix metalloproteinase (MMP)2:3-9
MEK3:10; 4:12; 5:12
melanocortin 1 receptor agonist2:10
melanoma2:10; 4:12; 5:12
Merkel cell carcinoma2:10
metabolic syndrome5:1-7
methotrexate1:8; 3:7
microbiome4:12
microscopic polyangiitis3:5-9
minocycline1:8; 2:10; 4:12
mitogen-activated protein kinase3:10; 4:12; 5:12
monkey pox vaccine2:11
monoclonal antibody1:8; 2:10,11; 3:1-4,10; 4:12

N

Nd:YAG laser4:1-5
Netherton syndrome4:12
neurofibromatosis type 13:10; 4:12
neurotoxin2:10
niacinamide5:8-11
nicotinamide5:8-11
non-alcoholic fatty liver disease5:3-4
non-melanoma skin cancer5:8-11
nutrient supplementation2:6-7
nutrition2:3-9

O

obesity5:1-7
Odomzo®5:12
Olumiant®3:10
Otezla®2:10
oxidation2:3-9

P

PD-1 inhibitor2:10; 4:12; 5:12
pediatric psoriasis5:1-7
pediculicide5:12
pegylated interferon alpha3:7
pembrolizumab2:10; 4:12
PF-049658424:7
PF-066516004:7
PF-067008414:7
phototoxicity2:10
picosecond laser4:2
plasma exchange3:7
Pliaglis®1:8
polycystic ovarian syndrome5:3
prabotulinumtoxinA2:10
primary vasculiltis3:5-9
programmed cell death 1 inhibitor2:10; 4:12
protein replacement therapy4:12
pruritus1:8
psoriasis1:8; 2:10,11; 3:1-4,10; 4:6-8,12; 5:1-7,12
psoriatic arthritis1:8; 2:10,11; 3:10; 4:12; 5:1-7,12
psychiatric disturbances5:4
pruritus4:1-5

Q

Q-switched laser4:3
quality of life5:1-7
Quzyttir™1:8; 2:11
Qwo™4:12

R

Remicade®1:8; 2:11; 3:10
Retinoic acid receptor gamma1:8; 2:1-2
retinoid1:6,8; 2:1-2,10-12; 5:12
risankizumab2:11; 3:1-4
Rituxan®2:10
rituximab2:10,12; 3:7
rosacea4:12
ruxolitinib2:10; 4:6-11

S

Scenesse®2:10
seborrheic keratosis1:1-4
secondary vasculitis3:6
selumetinib3:10; 4:12
Simponi®Aria™5:12
skin aging2:3-9
skin of color4:1-5
Skyrizi™2:11
smallpox vaccine2:11
small-vessel vasculitis (primary)3:5-9
sonidegib5:12
squamous cell carcinoma4:12; 5:8-11
Staphylococcus epidermidis4:12
Stelara®5:12
systemic lupus erythematosus2:11; 4:6-11

T

Taclonex®2:11
tazarotene2:10,11,12
tazemetostat2:10,12
Tazverik™2:10,12
Tecentriq®5:12
tetracaine1:8
tetracycline5:11
thromboembolism4:9-10
TNF-alpha1:8; 2:10,11; 3:10; 4:12; 5:12
tofacitinib4:6-11
transepidermal water loss1:5
Tremfya®4:12
trifarotene1:8; 2:1-2
truncal acne2:1-2
tryptophan5:8
tumor necrosis factor-alpha1:8; 2:10,11; 3:10; 4:12; 5:12

U

ultraviolet radiation damage2:7
upadacitinib4:7
urticaria1:8; 2:11
ustekinumab5:12
uveitis5:3

V

vaccine2:11
vasculitides3:5-9
vemurafenib5:12
vitamin B35:8-11
vitamin D2:11; 5:12
vitiligo4:6-11

W

Winlevi®5:12
Wynzora®5:12

X

Xeglyze™5:12
X-linked hypohidrotic ectodermal dysplasia4:12

Y

Z

Zelboraf®5:12
Zilxi™4:12